Published: May, 2018
The global orthobiologics market is predicted to testify frequent product approval. This could be evident with the launch of NuVasive’s AttraX Putty, a next-gen biologics technology in 2016. The product was introduced with the intention of gaining an edge over competitors and expanding the company’s product portfolio. In a report by Transparency Market Research (TMR), leading players such as Globus Medical Inc., DePuy Synthes Inc., and Bacterin International Inc. have been profiled while focusing on their key developments and other aspects. The competitive landscape could be marked by the practice of certain business tactics including mergers and acquisitions, distribution improvement, collaborations, and new product development.
As per the findings of TMR, a US$5.5 bn valuation could be achieved by the global orthobiologics market by the end of 2019. On the basis of product, viscosupplementation is expected to score a king’s share of the market. In terms of regional growth, Europe and North America could rank higher in the coming years.
Increasing Procedures Carried out for Musculoskeletal Problems Expedite Growth
Orthobiologics is used to accelerate skeletal and tissue healing. In recent years, it has managed to come to the fore due to limitations of allografts and autografts in the treatment of bone injuries and osteoarthritis. One of the primary factors augmenting the demand in the world orthobiologics market could be rising count of treatment procedures performed for musculoskeletal conditions.
Massive demand for knee treatment surgeries is forecasted to set the tone for valuable growth in the viscosupplementation market for orthobiologics. Another reason for the rise of this market could be greater efficiency of viscosupplementation products in comparison with non-steroidal anti-inflammatory drugs (NSAIDs). Plunging sales of Medtronic’s INFUSE could help the bone morphogenetic proteins (BMPs) market to increase its growth further.
Inadequacy of Reimbursement Policies that Show Transparency Hinders Rise in Demand
Regulatory mandates for treatment and lack of transparent reimbursement policies are envisaged to delay growth in the international orthobiologics market. However, the market could offer profit-making prospects in the coming years, especially in developed regions where the incidence of obesity and arthritis is particularly high. Demand for minimally invasive procedures is observed to grow massive due to the rise of these diseases. These procedures could include growth factor and bone grafting treatments.
Furthermore, medical practitioners and patients having an inclination toward the use of stem-cell-based products could fortify the rise of stem cell therapy in the near future. According to a TMR analyst, synthetic bone substitutes and stem-cell-based products are foretold to register telling growth in future years. Rising adoption of sedentary lifestyle, increasing count of sports injuries, and swelling geriatric population could help the orthobiologics market to showcase growth in Asia Pacific. This regional market is projected to grow decently in the near term.
The information presented in this review is based on a TMR report, titled “Orthobiologics Market (Product - Bone Morphogenetic Proteins, Demineralized Bone Matrix, Synthetic Bone Substitutes, Viscosupplementation, Allografts, Stem Cell Therapy, and Machined Bones; Application - Spinal Fusion, Trauma, and Reconstructive Surgery) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.”
The global orthobiologics market has been segmented as presented below:
Global Orthobiologics Market by Product
- Bone Morphogenetic Proteins
- Demineralized Bone Matrix
- Synthetic Bone Substitutes
- Stem Cell Therapy
- Machined Bones
Global Orthobiologics Market by Application
- Spinal Fusion
- Reconstructive Surgery
Global Orthobiologics Market by Region
- North America
- Asia Pacific
- Rest of the World
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453